These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34818472)

  • 41. Behçet's disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study.
    Uluduz D; Midi I; Duman T; Colakoglu S; Tüfekci A; Bakar M; Nazliel B; Tascilar N; Goksan B; Sungur MA; Kozak HH; Demir S; Misirli CH; Kucukoglu H; Cinar N; Domac FM; Ozturk S; Yayla V; Karahan AY; Afsar N; Goksu EO; Mengulluoglu N; Aytac E; Yesilot N; Ince B; Yalin OO; Oruc S; Demirci S; Senol MG; Yilmaz A; Gokce M; Yilmaz Kusbeci Ö; Uzuner G; Batur Caglayan HZ; Acikgoz M; Zeydan B; Ozdag F; Baybas S; Ekmekci H; Cabalar M; Yaman M; Yurekli VA; Tekeli H; Genc H; Utku U; Ucan Tokuc FE; Uzuner N; Bektas H; Kablan Y; Goksel BK; Milanlioglu A; Necioglu Orken D; Aluclu U
    Rheumatology (Oxford); 2019 Apr; 58(4):600-608. PubMed ID: 29992235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paediatric Behçet's disease with sinus venous thrombosis: experience from three centres in Turkey.
    Demir S; Acari C; Basaran O; Sağ E; Karlı Oğuz K; Bilginer Y; Ünsal SE; Özen S
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):147-151. PubMed ID: 31376249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium.
    Mehraein S; Ortwein H; Busch M; Weih M; Einhäupl K; Masuhr F
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):814-6. PubMed ID: 12754362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of Use of Dabigatran in Cerebral Venous Sinus Thrombosis.
    Nirhale S; Rohatgi S; Rao P; Naphade P; Hatekar KS
    Cureus; 2024 Jul; 16(7):e64744. PubMed ID: 39156380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis.
    Gunes HN; Cokal BG; Guler SK; Yoldas TK; Malkan UY; Demircan CS; Yon MI; Yoldas Z; Gunes G; Haznedaroglu IC
    J Int Med Res; 2016 Dec; 44(6):1454-1461. PubMed ID: 28222615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral venous sinus thrombosis after vestibular schwannoma surgery: a call for evidence-based management guidelines.
    Abou-Al-Shaar H; Gozal YM; Alzhrani G; Karsy M; Shelton C; Couldwell WT
    Neurosurg Focus; 2018 Jul; 45(1):E4. PubMed ID: 29961375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endovascular Mechanical Thrombectomy and On-Site Chemical Thrombolysis for Severe Cerebral Venous Sinus Thrombosis.
    Liao CH; Liao NC; Chen WH; Chen HC; Shen CC; Yang SF; Tsuei YS
    Sci Rep; 2020 Mar; 10(1):4937. PubMed ID: 32188921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment.
    Masuhr F; Mehraein S
    Neurocrit Care; 2004; 1(3):355-61. PubMed ID: 16174934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex Differences and Clinical Outcomes of Patients with Coronavirus Disease 2019 Infection and Cerebral Venous Sinus Thrombosis: A Systematic Review.
    Algarni SA; ALGhasab NS; Alharbi MS; Albarrak A; Alanezi AA; Al Shehri HM
    Clin Appl Thromb Hemost; 2024; 30():10760296241240748. PubMed ID: 38551022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
    Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
    JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study.
    Ibrahim EAA; Hassan Mohamed RE; Hussien Mohamed Ahmed KA; Haroun MS; Abdalla YA; Abdalla Omer ME; Mahmmoud Fadelallah Eljack M
    Ann Med Surg (Lond); 2022 Dec; 84():104891. PubMed ID: 36536723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis.
    Sadeghi Hokmabadi E; Daei Sorkhabi A; Sarkesh A; Sadigh-Eteghad S; Mehdizadehfar E; Sadeghpoor Y; Farhoudi M
    Acta Neurol Belg; 2024 Jul; ():. PubMed ID: 38985242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The outcomes of pregnant and postpartum patients with cerebral venous sinus thrombosis after anticoagulant therapy.
    Meng SH; Li JH; Zuo LJ; Feng LM
    Medicine (Baltimore); 2021 Jul; 100(26):e26360. PubMed ID: 34190153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
    Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
    Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
    JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.
    Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Chest; 2019 Feb; 155(2):354-363. PubMed ID: 30472021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.